XML 94 R74.htm IDEA: XBRL DOCUMENT v2.4.0.8
15. Quarterly Financial Data (Details) (USD $)
12 Months Ended 3 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Mar. 31, 2012
2007 through 2011 [Member]
Dec. 31, 2013
Scenario, Actual [Member]
Sep. 30, 2013
Scenario, Actual [Member]
Jun. 30, 2013
Scenario, Actual [Member]
Mar. 31, 2013
Scenario, Actual [Member]
Dec. 31, 2012
Scenario, Actual [Member]
Sep. 30, 2012
Scenario, Actual [Member]
Jun. 30, 2012
Scenario, Actual [Member]
Mar. 31, 2012
Scenario, Actual [Member]
Dec. 31, 2013
Scenario, Adjustment [Member]
Sep. 30, 2013
Scenario, Adjustment [Member]
Jun. 30, 2013
Scenario, Adjustment [Member]
Mar. 31, 2013
Scenario, Adjustment [Member]
Dec. 31, 2012
Scenario, Adjustment [Member]
Sep. 30, 2012
Scenario, Adjustment [Member]
Jun. 30, 2012
Scenario, Adjustment [Member]
Mar. 31, 2012
Scenario, Adjustment [Member]
Dec. 31, 2013
Scenario, Previously Reported [Member]
Sep. 30, 2013
Scenario, Previously Reported [Member]
Jun. 30, 2013
Scenario, Previously Reported [Member]
Mar. 31, 2013
Scenario, Previously Reported [Member]
Dec. 31, 2012
Scenario, Previously Reported [Member]
Sep. 30, 2012
Scenario, Previously Reported [Member]
Jun. 30, 2012
Scenario, Previously Reported [Member]
Mar. 31, 2012
Scenario, Previously Reported [Member]
Quantifying Misstatement in Current Year Financial Statements [Line Items]                                                        
Net sales $ 2,132,694,000 $ 2,069,235,000 $ 2,073,529,000   $ 602,600,000 $ 505,100,000 $ 525,300,000 $ 499,700,000 $ 573,800,000 $ 498,700,000 $ 510,400,000 $ 486,300,000 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 602,600,000 $ 505,100,000 $ 525,300,000 $ 499,700,000 $ 573,800,000 $ 498,700,000 $ 510,400,000 $ 486,300,000
Gross profit 1,178,478,000 1,155,158,000 1,178,829,000   322,700,000 284,200,000 300,100,000 271,400,000 314,500,000 273,800,000 288,100,000 278,700,000 0 0 0 0 400,000 300,000 200,000 100,000 322,700,000 284,200,000 300,100,000 271,400,000 314,100,000 273,500,000 287,900,000 278,600,000
Net income attributable to Bio-Rad 77,790,000 165,477,000 179,013,000   30,100,000 (7,100,000) 34,600,000 20,200,000 43,200,000 42,600,000 48,100,000 31,500,000 0 0 (100,000) 700,000 1,200,000 200,000 (200,000) 500,000 30,100,000 (7,100,000) 34,700,000 19,500,000 42,000,000 42,400,000 48,300,000 31,000,000
Basic earnings per share $ 2.72 $ 5.85 $ 6.39   $ 1.05 $ (0.25) $ 1.21 $ 0.71 $ 1.52 $ 1.51 $ 1.70 $ 1.12 $ 0.00 $ 0.00 $ (0.01) $ 0.03 $ 0.04 $ 0.01 $ (0.01) $ 0.02 $ 1.05 $ (0.25) $ 1.22 $ 0.68 $ 1.48 $ 1.50 $ 1.71 $ 1.10
Diluted earnings per share $ 2.69 $ 5.78 $ 6.29   $ 1.04 $ (0.25) $ 1.20 $ 0.70 $ 1.51 $ 1.49 $ 1.68 $ 1.10 $ 0.00 $ 0.00 $ 0.00 $ 0.02 $ 0.05 $ 0.01 $ (0.01) $ 0.01 $ 1.04 $ (0.25) $ 1.20 $ 0.68 $ 1.46 $ 1.48 $ 1.69 $ 1.09
Quantifying Misstatement Amount       $ 6,100,000